Nancy Whiting is a seasoned biotech executive currently serving as the President and Chief Executive Officer of Recludix Pharma, a role they have held since 2021. In addition to their leadership at Recludix, Nancy is a board member at Caribou Biosciences and Boundless Bio. Their extensive experience includes positions such as Vice President, Head of Medical Affairs at Seagen and Senior Oncology Medical Scientist at GSK. Nancy holds a Pharm.D. from the University of Washington and a B.Sc.(Pharm) from The University of British Columbia. With exceptional leadership skills and a strong background in oncology, they are passionate about advancing drug development to help patients.
This person is not in the org chart
This person is not in any teams
This person is not in any offices